Partnership Opportunities
Explore Related Events:
Introducing the Cell Therapies Event Series, a collection of 26 established events curated to enable this community to achieve their clinical and commercial potential.
Having trouble downloading the brochure? Let us know here and we'll email it to you instead.
Establish Your Brand as the Go-To in the Rapidly Expanding TIL Field
With an eruption of excitement in TIL therapies since Lifileucel’s approval, now is the time to position yourself as an expert at the 6th Annual TIL Therapies Summit. Here, you can grow with the field, get in on the ground floor, and establish your company as a market leader within this community.
Meet C-level executives, directors, and VPs from top TIL companies including Iovance Biotherapeutics, Obsidian Therapeutics, and Lyell Immunopharma to boost your presence in this pivotal field.
Showcase your expertise in this summit through podium presentations, moderating panel discussions, and hosting roundtables to put the spotlight on your dedicated solutions.
Why Partner?
Spotlight your dedicated solutions to an engaged and close-knit audience ensuring you make intimate connections and accelerate partnerships
Build relationships with senior decision makers and stakeholders to drive your commercial and strategic goals with your focused target audience
Establish your brand in a niche and rapidly expanding market where many stakeholders are still looking for the go-to expert in all things TIL
Our 2024 Partners:
Who Could You Meet?
Experts Need Your Help With:
Product Manufacturing
Scaling manufacturing of TIL products in a GMP compliant facility including cell, protein, and antigen manufacturing
GLP/GMP Compliant Translational Studies
Providing appropriate animal models, expertise in animal handling and testing
Assay Development, Qualification and Validation
Expertise in designing, optimizing, and validating assays for product characterization and potency determination
Media and Reagent Provision
Appropriate and high-quality tissue, blood, and culture media provision. Procurement of cell therapy laboratory reagents
Instrumentation
Sensitive and cutting-edge instruments including bioreactors, automated flow cytometry, ddPCR, and more
Gene Engineering:
Provision of editing components including viral vectors, proteins, and plasmids. Expertise in engineering autologous therapies
Regulatory Guidance
Assistance in navigating complex regulatory requirements and ensuring compliance from IND-IMPD through to BLA and commercialization